Trozzi, Ilaria; Giorgi, Beatrice; De Paola, Riccardo; Gatti, Milo; Pea, Federico, Accurate and Sensitive UHPLC–Tandem Mass Spectrometry Sequential Methods for Therapeutic Drug Monitoring of Aztreonam/Avibactam in Human Plasma, «PHARMACEUTICS», 2026, 10.3390/pharmaceutics18030377, pp. 1 - 15 [Scientific article]
Gatti, Milo; Rinaldi, Matteo; Laici, Cristiana; Ambretti, Simone; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico, Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime–avibactam in a case series of orthotopic liver transplant recipients, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2026, 81, Article number: dkag009 , pp. 1 - 5 [Scientific article]Open Access
Gatti, Milo; De Paola, Riccardo; Giorgi, Beatrice; Pea, Federico, Comparison of ceftolozane-tazobactam and ceftazidime-avibactam in the treatment of MDR/DTR
Pseudomonas aeruginosa
infections: a systematic review and meta-analysis, «CLINICAL INFECTIOUS DISEASES», 2026, 10.1093/cid/ciag194, pp. 1 - 23 [Scientific article]
Gatti, Milo; Pea, Federico, Pharmacological approaches to overcome antimicrobial resistance to novel beta-lactams in MDR Gram-negative bacterial infections: Current practice and future directions, «EXPERT OPINION ON PHARMACOTHERAPY», 2026, 10.1080/14656566.2026.2651279, pp. 1 - 19 [Scientific article]
Gatti, Milo; Pea, Federico, Raising the Bar of PK/PD Target Attainment of Beta-Lactams in Daily Clinical Practice: An Effective Strategy to Overcome Resistance Development to Novel Beta-Lactams?, «INFECTIOUS DISEASE REPORTS», 2026, 18, Article number: 3 , pp. 1 - 4 [Scientific article]Open Access
Gatti, Milo; Pea, Federico, Real-World Evidence and Multidrug Resistant Infections: How Can We Leverage RWE to Improve Patient Outcome with the Novel Beta-Lactam and Beta-Lactam/Beta-Lactamase Inhibitor Combinations, «INFECTION AND DRUG RESISTANCE», 2026, Volume 19, pp. 1 - 23 [Scientific article]
Trozzi, Ilaria; Giorgi, Beatrice; De Paola, Riccardo; Gatti, Milo; Pea, Federico, Two Comprehensive Liquid Chromatography High-Resolution Mass Spectrometry (UPLC-MS/MS) Multi-Methods for Real-Time Therapeutic Drug Monitoring (TDM) of Five Novel Beta-Lactams and of Fosfomycin Administered by Continuous Infusion, «PHARMACEUTICS», 2026, 18, Article number: 91 , pp. 1 - 20 [Scientific article]Open Access
Di Bella, Stefano; Geremia, Nicholas; Pea, Federico; Zeitlinger, Markus; Sanson, Gianfranco; Monticelli, Jacopo; Bergmann, Felix; Motet, Christian; Lambotte-Buffet, Christophe; Zerbato, Verena; Gatti, Milo, When and How to Use Subcutaneous Antibiotics, «CLINICAL INFECTIOUS DISEASES», 2026, 10.1093/cid/ciaf691, pp. 1 - 12 [Scientific article]
Gatti, Milo; Rinaldi, Matteo; Cojutti, Pier Giorgio; Bonazzetti, Cecilia; Siniscalchi, Antonio; Tonetti, Tommaso; Ambretti, Simone; Tedeschi, Sara; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-producing Klebsiella pneumoniae infections and on ceftazidime/avibactam resistance development, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2025, 69, pp. 1 - 12 [Scientific article]Open Access
Gatti, M.; Rinaldi, M.; Bonazzetti, C.; Siniscalchi, A.; Tonetti, T.; Ambretti, S.; Giannella, M.; Viale, P.; Pea, F., A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: A strategy useful for raising the bar?, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2025, 80, pp. 1543 - 1551 [Scientific article]Open Access
Bonazzetti, Cecilia; Rocchi, Ettore; Toschi, Alice; Derus, Nicolas Riccardo; Sala, Claudia; Pascale, Renato; Rinaldi, Matteo; Campoli, Caterina; Pasquini, Zeno Adrien Igor; Tazza, Beatrice; Amicucci, Armando; Gatti, Milo; Ambretti, Simone; Viale, Pierluigi; Castellani, Gastone; Giannella, Maddalena, Artificial Intelligence model to predict resistances in Gram-negative bloodstream infections, «NPJ DIGITAL MEDICINE», 2025, 8, Article number: 319 , pp. 1 - 6 [Scientific article]Open Access
Rinaldi, M.; Gatti, M.; Giannella, M., Avoiding resistance development to newer drugs: open research lines, «CLINICAL MICROBIOLOGY AND INFECTION», 2025, 32, pp. 543 - 553 [Scientific article]Open Access
Donker, E. M.; Piët, J. D.; Brinkman, D. J.; Richir, M. C.; Papaioannidou, P.; Likic, R.; Sanz, E. J.; Christiaens, T.; Costa, J. N.; De Ponti, F.; Gatti, M.; Böttiger, Y.; Kramers, C.; Van Agtmael, M. A.; Tichelaar, J., Barriers and solutions for the European prescribing exam: a qualitative world café study, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2025, 81, pp. 1451 - 1459 [Scientific article]Open Access
Caselli, D.; Arico, M.; Castagnola, E.; Gatti, M., Bridging the Gap: A Systematic Review with Expert Opinion on the Use of Dalbavancin for In-Label and Off-Label Indications in Pediatric Patients, «ANTIBIOTICS», 2025, 14, Article number: 121 , pp. 1 - 17 [Scientific article]Open Access
Gatti, Milo; Pea, Federico, Critical reappraisal of current issues for improving the proper clinical use of the incoming beta-lactam/beta-lactamase inhibitor combinations of tomorrow, «EXPERT REVIEW OF ANTI-INFECTIVE THERAPY», 2025, N/A, pp. 1 - 37 [Scientific article]